Adaptive Biotechnologies Chief Commercial Officer Susan Bobulsky disposes of 5,000 shares for $115,000
ADPT•Insider share sale disclosed
- Adaptive Biotechnologies Chief Commercial Officer, MRD Susan Bobulsky sold 5,000 common shares on July 16, 2026 at $23 per share.
- Direct holdings fell to 401,288 shares following the transaction.
Related News
Goldman Sachs on TTF: Estimates that faster-than-expected ramp of Hormuz flows would allow TTF to sell off back in line with the coal-to-gas switching threshold of 40 EUR/MWh
XLE•
Tuya Smart invests in Robopoet in RMB 100 million pre-A funding round
TUYA•
